Patent Ductus Arteriosus: Clinical Trials

86 trials for Patent Ductus Arteriosus, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

43 completed, 21 unknown, 10 terminated, 4 active not recruiting. 21 Not applicable, 13 Phase 2, 9 Phase 3, 7 Phase 4, 3 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable21Completed 15, Terminated 3, Unknown 3
Phase 213Unknown 6, Completed 2, Terminated 2, Withdrawn 2, Recruiting 1
Phase 39Completed 5, Terminated 2, Active not recruiting 1, Unknown 1
Phase 47Completed 3, Terminated 2, Unknown 2
Phase 13Completed 1, Terminated 1, Unknown 1
Early Phase 11Completed 1

Follow Patent Ductus Arteriosus: new trials by email Literature Review of Patent Ductus Arteriosus trials Research Report on Patent Ductus Arteriosus

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
HeartR™ PDA Occluder Post-Market Follow-Up Study
HeartR™ PDA Occluder - Patent Ductus Arteriosus
RecruitingLifetech Scientific (Shenzhen) Co., Ltd.1402025-04-302026-06-15
PDA for Kidneys Study
Near Infrared Spectroscopy - Patent Ductus Arteriosus, Congenital Heart Disease
Active not recruitingUniversity of Wisconsin, Madison272024-12-192026-09-21
NeoDoppler: New Ultrasound Technology for Continuous Monitoring of Cerebral Circulation Pilot
NeoDoppler - CE certified - Preterm, Patent Ductus Arteriosus
RecruitingSt. Olavs Hospital1802024-10-202026-04-23
Precision Dosing of Oral Ibuprofen for PDA, A Pilot RCT
Standard Dose - Ibuprofen oral suspension, Precision Dose - Ibuprofen oral suspension - Patent Ductus Arteriosus, Preterm
Phase 2RecruitingHamilton Health Sciences Corporation262024-07-042025-08-27
The Role of Thiamine After Transcatheter Closure in Children With Left-to-Right Shunt Congenital Heart Disease
Thiamine - Congenital Heart Disease, Thiamine Deficiency
Early Phase 1CompletedUniversitas Sumatera Utara862024-05-012026-03-24
Assessment of Therapeutic Effect of Rectal Vs. Intravenous Paracetamol in The Treatment of Patent Ductus Arteriosus (PDA) in Neonates
Paracetamol - Patent Ductus Arteriosus
Phase 1 / Phase 2UnknownSoha mahmoud Hussien mahdy1002024-03-012024-02-13
Comparision Between Paracetamol and Ibuprofen in Closure of Patent Ductus Arteriosus
Paracetamol, Ibuprofen - Patent Ductus Arteriosus
Phase 2UnknownAssiut University562023-12-012023-12-01
PUFAs in Preterm Infants
Necrotizing Enterocolitis, Intraventricular Hemorrhage
UnknownThe First Hospital of Jilin University6002023-09-212023-09-21
Liver Regional Oxygen Saturation in Preterm Patent Ductus Arteriosus
near-infrared spectroscopy based cerebral/somatic oximeter system (INVOS™ system manufactured by Medtronics) - Patent Ductus Arteriosus, Circulation
CompletedSeoul St. Mary's Hospital402023-01-132025-05-30
Post Marketing Clinical Follow Up Study to Evaluate Efficacy and Safety of the Occlutech PDA Occluder in Patients With Patent Ductus Arteriosus Defects
Occlutech® PDA Occluder - Patent Ductus Arteriosus
RecruitingOcclutech International AB2552021-12-202026-08-12
PAIR (Paracetamol and Ibuprofen Research) Pilot Trial
Paracetamol injection, Ibuprofen injection - Patent Ductus Arteriosus
Phase 2 / Phase 3UnknownManchester University NHS Foundation Trust322021-09-032023-10-30
Optimal Dose of Surfactant for Preterm Infants With Respiratory Distress Syndrome
PS is stopped when the pressure is equal between bPDA and aPDA., PS is given according to the 2019 European RDS management guideline - Respiratory Distress Syndrome, Newborn, Patent Ductus Arteriosus
Not applicableUnknownDaping Hospital and the Research Institute of Surgery of the Third Military Medical University3002021-08-012022-10-14
Aminoglycosides and Duct
echocardiography - Patent Ductus Arteriosus
UnknownCarmel Medical Center602021-07-012021-02-09
Effect of PDA Closure on the Left Ventricular Remodeling
speckle tracking echocardiography - Congenital Heart Defect, Patent Ductus Arteriosus
UnknownAhmed Mohamed Moheb El-Din482021-07-012021-07-16
Addition of Acetaminophen in Standard PDA Management
Intravenous Ibuprofen, Intravenous Ibuprofen + Oral Acetaminophen - Patent Ductus Arteriosus
Phase 2WithdrawnUniversity of Florida2021-04-012021-06-24
Clinical Profile of Neonates Having Patent Ductus Arteriosus
echocardiography - Patent Ductus Arteriosus
UnknownAssiut University302021-04-012021-03-05
Preliminary Percutaneous Intervention Versus Observational Trial of Arterial Ductus in Low-weight Infants
Cather closure of patent ductus arteriosus (PDA), Conservative management of patent ductus arteriosus (PDA) - Patent Ductus Arteriosus
Not applicableTerminatedNationwide Children's Hospital12020-10-102024-02-07
Ibuprofen vs Expectant Management for hsPDA in Preterm Infants: Retrospective Cohort
Ibuprofen - Patent Ductus Arteriosus, Infant, Premature
CompletedShengjing Hospital5412020-06-012026-04-16
Population Pharmacokinetics and Dosage Individualization of Paracetamol and Ibuprofen in Children With PDA
Paracetamol, Ibuprofen - Patent Ductus Arteriosus
UnknownShandong University5002020-05-252020-05-21
Amplatzer Piccolo Occluder Japan Post-marketing Database Surveillance
Amplatzer Piccolo Occluder - Patent Ductus Arteriosus
Active not recruitingAbbott Medical Devices702020-04-012026-10-06

Showing 20 of 86. Sign in to see all of them.

Narrower conditions

Ductus Arteriosus, Patent (86)  ·  Premature Birth (28)  ·  Bronchopulmonary Dysplasia (7)  ·  Heart Defects, Congenital (6)  ·  Enterocolitis, Necrotizing (5)  ·  Heart Septal Defects, Atrial (5)  ·  Apnea (2)  ·  Bradycardia (2)  ·  Heart Septal Defects, Ventricular (2)  ·  Hypertension, Pulmonary (2)  ·  Leukomalacia, Periventricular (2)  ·  Respiratory Distress Syndrome (2)  ·  Sepsis (2)  ·  Aortic Coarctation (1)  ·  Aortic Valve Stenosis (1)

Broader conditions

Cardiovascular Abnormalities (86)  ·  Congenital Abnormalities (86)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (86)  ·  Heart Diseases (86)  ·  Cardiovascular Diseases (85)  ·  Heart Defects, Congenital (80)  ·  Female Urogenital Diseases and Pregnancy Complications (28)  ·  Obstetric Labor Complications (28)  ·  Obstetric Labor, Premature (28)  ·  Pregnancy Complications (28)  ·  Urogenital Diseases (28)  ·  Respiratory Tract Diseases (13)  ·  Lung Diseases (11)  ·  Infant, Newborn, Diseases (9)  ·  Infant, Premature, Diseases (7)

Interventions

Ibuprofen (27)  ·  Acetaminophen (18)  ·  Indomethacin (9)  ·  Echocardiography (3)  ·  Spectroscopy, Near-Infrared (3)  ·  Anti-Inflammatory Agents, Non-Steroidal (2)  ·  Conservative Treatment (2)  ·  Cyclooxygenase Inhibitors (2)  ·  Watchful Waiting (2)  ·  Angptl4 protein, mouse (1)  ·  Injections (1)  ·  Magnetic Resonance Imaging (1)  ·  Pentoxifylline (1)  ·  Sodium Chloride (1)  ·  Thiamine (1)

Sponsors

Shaare Zedek Medical Center (7)  ·  Albany Medical College (4)  ·  IRCCS Azienda Ospedaliero-Universitaria di Bologna (4)  ·  University of Florida (4)  ·  Abbott Medical Devices (3)  ·  Lifetech Scientific (Shenzhen) Co., Ltd. (3)  ·  University of California, San Francisco (3)  ·  University of Utah (3)  ·  Zekai Tahir Burak Women's Health Research and Education Hospital (3)  ·  Assiut University (2)  ·  Nationwide Children's Hospital (2)  ·  Occlutech International AB (2)  ·  Ahmed Mohamed Moheb El-Din (1)  ·  Ain Shams University (1)  ·  Alan Fujii (1)

Countries

United States (29)  ·  Israel (7)  ·  Turkey (Türkiye) (6)  ·  China (5)  ·  France (5)  ·  Italy (5)  ·  Canada (4)  ·  United Kingdom (4)  ·  Germany (3)  ·  Sweden (3)  ·  Indonesia (2)  ·  Malaysia (2)  ·  Switzerland (2)  ·  Tunisia (2)  ·  Algeria (1)

Top investigators

Cathy Hammerman, MD (5)  ·  Carl H Backes, MD (2)  ·  Ronald Clyman, M.D. (2)  ·  Silvia Martini, MD (2)  ·  Adelina Pellicer, PhDMD (1)  ·  Alan M Fujii, MD (1)  ·  Alwi Mazeni, Dr (1)  ·  Amish Jain, MBBS, PhD (1)  ·  Amuchou S Soraisham, MD, DM (1)  ·  Arin Mukherjee, MRCPCH (1)  ·  Curt DeGroff, MD (1)  ·  D Sc Lim, MD (1)  ·  Dan L Stewart, MD (1)  ·  Daniel K Benjamin, MD PhD MPH (1)  ·  Dmytro Dobryanskyy, MD, PhD (1)

Results publications

PMID 22065264, PMID 26283668, PMID 16322159, PMID 17564958, PMID 18628265, PMID 19047225, PMID 19217726, PMID 19902266, PMID 19956811, PMID 20336076, PMID 20336077, PMID 20368313, PMID 21094951, PMID 21760564, PMID 22284563, PMID 23258386, PMID 23472765, PMID 24223740, PMID 24321538, PMID 24359938, PMID 24854626, PMID 25653299, PMID 26168357, PMID 26244949, PMID 26672023, PMID 26951240, PMID 28395364, PMID 28874164, PMID 29695206, PMID 29943734, PMID 30077184, PMID 30340932, PMID 30850756, PMID 30940676, PMID 31211764, PMID 31255386, PMID 31519154, PMID 32433821, PMID 33301630, PMID 33307111, PMID 33952559, PMID 34147090, PMID 34293369, PMID 34526095, PMID 34675131, PMID 36477458, PMID 36519620, PMID 37587183, PMID 37659585, PMID 41364689

NIH funding

2019 (1), R01HL145032 (1), UG1HD112079 (1), UG1HD112097 (1), UG1HD112100 (1)